PCa radiotherapy raises bladder, rectal Ca risk

Tennant, Scott
September 2008
Urology Times;9/1/2008, Vol. 36 Issue 11, p21
The article reports on the study which reveals that men who receive radiotherapy for treatment of localized prostate cancer have an elevated risk of developing bladder and rectal cancer. The study showed that the relative risk of developing bladder cancer was 1.88 after external beam radiation therapy, 1.52 after brachytherapy, and 1.85 after combination therapy. It suggests urologists to be aware that there may be a subset of patients for whom prostatectomy is a better option that radiation.


Related Articles

  • In low-risk PCa, QoL is key to treatment choice. Sleve, Vonne // Urology Times;8/1/2008, Vol. 36 Issue 9, p10 

    The article discusses the significance of active surveillance, interstitial prostate brachytherapy, and external beam radiotherapy in treating patients with low-risk localized prostate cancer. The technique's focus is to treat side effects and their impact on quality of life. In a study, men who...

  • Three modalities show equal outcomes in localized PCa. Guttman, Cheryl // Urology Times;Jun2004, Vol. 32 Issue 8, p1 

    Reports that three modalities show equal outcomes in localized prostate cancer. Monotherapy with radical prostatectomy; External beam radiation therapy; Permanent prostate brachytherapy.

  • New Weapons Against Prostate Cancer. Saltus, Richard // Popular Science;Aug2000, Vol. 257 Issue 2, p58 

    Provides information on several treatments for prostate cancer. Radical prostatectomy; External-beam therapy; Brachytherapy; X-ray treatment. INSETS: Catching Cancer Early;Hope from Herbs.

  • Use of brachytherapy for localized prostate cancer has declined. Todak, Alexandra // Hem/Onc Today;6/10/2014, Vol. 15 Issue 11, p7 

    The article reports on the downturn in the use of brachytherapy as treatment for men with lower-risk prostate cancer based on information from National Cancer Data Base institutions and mentions topics including rise in utilization of radical prostatectomy and active surveillance.

  • Making the Case for Brachytherapy. Sarosdy, Michael F. // Renal & Urology News;May2012, Vol. 11 Issue 5, p27 

    An interview with South Texas Urology & Urologic Oncology founder Michael F. Sarosdy in San Antonio, Texas is presented. He says that brachytherapy is a one-time outpatient treatment which only requires about one hour in the operating room (OR). He states that the shift in intensity-modulated...

  • Canadian prostate brachytherapy in 2012. Keyes, Mira; Crook, Juanita; Morris, W. James; Morton, Gerard; Pickles, Tom; Usmani, Nawaid; Vigneault, Eric // Canadian Urological Association Journal;Feb2013, Vol. 7 Issue 1/2, p51 

    Prostate brachytherapy can be used as a monotherapy for low- and intermediate-risk patients or in combination with external beam radiation therapy (EBRT) as a form of dose escalation for selected intermediate- and high-risk patients. Prostate brachytherapy with either permanent implants (low...

  • THE PROSTATE PARADOX. Groopman, Jerome // New Yorker;05/29/2000, Vol. 76 Issue 13, p52 

    Discusses several techniques for treating prostate cancer. Details on the biopsy procedure; Function of the prostate gland; Number of men in the United States diagnosed with prostate cancer; Margin of error in prostate cancer surgery; Radiation treatment for prostate cancer; Brachytherapy technique.

  • Management of Prostate Cancer. Roach, Mack // New England Journal of Medicine;12/11/2008, Vol. 359 Issue 24, p2605 

    The article presents recommendations for the management of prostate cancer for the case of a 63 year old man with a rising prostate-specific antigen (PSA) level. The author recommends a permanent radioactive prostate seed implant, a form of brachytherapy. He explains that permanent prostate seed...

  • Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile. Beydoun, Nadine; Bucci, Joseph; Malouf, David // Journal of Contemporary Brachytherapy;2014, Vol. 6 Issue 1, p15 

    Purpose: Prostate cancer is among the most common non-cutaneous neoplasms affecting renal transplant recipients (RTRs). Available treatments including radical prostatectomy and external beam radiotherapy carry a risk of damage to the transplanted kidney, ureters, or bladder. We assessed the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics